Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPAS1 | Q99814 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 17/20 | 0.46 |
| ▸ | EP300 | Q09472 | 2/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.44 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.42 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | TSPO | P30536 | 1/20 | 0.41 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.41 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28718898 | 1.00 | EPAS1 (0.47) | EPAS1BRD4EP300MAPK14MRGPRX1 | |
| SCHEMBL29549377 | 0.87 | BRD4 (0.51) | EPAS1BRD4EP300MAPK14MRGPRX1 | |
| SCHEMBL28720338 | 0.87 | BRD4 (0.51) | EPAS1BRD4EP300MAPK14MRGPRX1 | |
| SCHEMBL16335750 | 0.85 | BRD4 (0.47) | EPAS1BRD4EP300MAPK14BRD2 | |
| SCHEMBL16335784 | 0.85 | BRD4 (0.56) | EPAS1BRD4MAPK14MRGPRX1 | |
| SCHEMBL15067642 | 0.84 | BRD4 (0.57) | EPAS1BRD4MAPK14MRGPRX1 | |
| SCHEMBL15067921 | 0.84 | BRD4 (0.58) | EPAS1BRD4EP300MAPK14BRD2 | |
| SCHEMBL16335606 | 0.83 | BRD4 (0.45) | EPAS1BRD4EP300MAPK14BRD2 | |
| SCHEMBL20443102 | 0.83 | BRD4 (0.46) | EPAS1BRD4MAPK14 | |
| SCHEMBL15067364 | 0.83 | BRD4 (0.58) | EPAS1BRD4MAPK14MRGPRX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110041253-B | Pyridine N-oxide derivative and preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2022-03-29 | — | — | CN | disclosed |